1001-16: Benzodiazepines: Boon or Boondoggle and Counteraction

4.75 (32 votes)

Recorded On: 06/09/2016

  • Registration Closed

1001-16: Benzodiazepines: Boon or Boondoggle and Counteraction

An in-depth look at the pharmacokinetics and pharmacodynamics of benzodiazapines. Everything you need to develop knowledge and skill in assisting clients to withdraw from long-term use of benzodiazepines.

Presenter: Barbara Limandri, PhD, PMHNP, BC

Disclosures: The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.

Session Length:  1 Hour 45 minutes

Target Audience:  RN, APRN

Session Objectives:
Upon completion of this presentation, the participant will be able to:
1. Explain the issues of prescribing patterns of benzodiazepines in the United States.
2. Review the mechanisms of action of benzodiazepines in relation to treatment outcomes.
3. Discuss protocols for benzodiazepine withdrawal and discontinuation.

Keywords: Benzodiazepines, Psychopharmacology, Protocols for Benzodiazepine Withdrawls

Continuing Nursing Education
2.0 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 14th Annual Clinical Psychopharmacology Institute
Hyatt Regency Baltimore on the Inner Harbor
Thursday, June 9, 2016
5:00pm – 7:00pm

Release Date: July 29, 2016
The contact hours for this session expire: September 1, 2019

Components visible upon registration.